Cigna Group (CI)

Cigna (CI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

CI expands coverage to Cleerly's AI cardiovascular imaging, boosting access, early detection and digital healthcare adoption.

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Heartflow secures FDA clearance and Cigna coverage for its Next Gen Plaque Analysis, boosting accuracy and nationwide access.

DENVER--(BUSINESS WIRE)-- #AI--Cleerly, a leader in AI-based cardiovascular imaging, today announced that Cigna will begin covering Cleerly LABS Advanced Plaque Analysis effective October 1, 2025. The...

Cigna provides a market-beating dividend with plenty of room for further growth. The company topped analysts' expectations for revenue and adjusted EPS in Q2. Cigna's A-rated balance sheet gives it th...

The Medical-HMO industry benefits from strength in commercial plans, M&A and expected Medicare rate hikes, but rising costs, regulatory shifts and workforce shortages strain margins. CI and HUM are li...

Cigna said on Wednesday the percentage of employers paying for obesity drugs has remained flat year-over-year, though the health insurer still sees an uptick in demand for the wildly popular treatment...

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (Sept. 2025)

Barclays raised the firm's price target on Cigna to $383 from $354 and keeps an Overweight rating on the shares. The firm adjusted estimates and targets in the managed care and healthcare facility gro...